 |
市場調查報告書
商品編碼
2024207
全球基因表現分析市場：依產品、應用、最終用戶和地區分類－預測至2031年Gene Expression Analysis Market by Product, Service, Application, End User, and Region - Global Forecast to 2031 |
||||||
價格
預計到 2031 年，基因表現分析市場規模將達到 59.3 億美元，高於 2026 年的 42.3 億美元，預測期內複合年成長率為 7.0%。
轉錄組學技術的日益普及以及人們對精準醫療和個人化治療日益成長的興趣，是推動這一市場發展的因素。次世代定序、PCR和微陣列等技術能夠對基因活性進行精確、高通量的分析，進而促進疾病研究和診斷的進展。
| 調查範圍 | |
|---|---|
| 調查期 | 2026-2031 |
| 基準年 | 2025 |
| 預測期 | 2026-2031 |
| 目標單元 | 金額（10億美元） |
| 部分 | 按產品/服務、按應用、按最終用戶、按地區 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲 |
此外，基因表現分析在生物標記發現和藥物研發的應用日益廣泛，有助於提高研究效率和臨床療效。然而，設備高成本、數據分析複雜以及對專業技術人員的需求仍然限制市場成長。
“預計在預測期內，試劑和耗材細分市場的複合年成長率將最高。”
由於試劑盒、酵素、探針和其他耗材在研究和臨床工作流程中反覆且大量使用，預計試劑和耗材細分市場將以最高的複合年成長率 (CAGR) 在基因表現分析市場中成長。這些產品對於 PCR、次世代定序和微陣列分析等技術至關重要，從而確保了穩定的需求。基因表現譜分析在診斷和藥物發現研究中的日益普及，以及基因組學和轉錄組學研究的興起，進一步推動了該細分市場的成長。此外，持續的產品創新以及對可靠、高品質試劑以確保結果準確性的需求，也促進了該細分市場的擴張。由於其成本績效和重複採購的特性，試劑和耗材是市場成長要素。
“藥物發現和開發領域佔據最大的市場佔有率。”
藥物發現與開發領域佔據基因表現基因表現分析在識別和檢驗藥物標靶方面的廣泛應用。這些技術在理解基因功能、疾病路徑和治療反應方面發揮著至關重要的作用，從而提高了藥物發現過程的效率。製藥和生物技術公司越來越依賴基因表現分析來進行生物標記發現、毒性評估和療效評估。精準醫療和標靶治療的日益普及，以及研發投入的不斷增加，進一步鞏固了該領域的領先地位。
“預計美國在預測期內將以最高的複合年成長率成長。”
美國基因表現分析市場預計將以最高的複合年成長率成長，這主要得益於領先的生物技術和製藥公司在該市場的強大影響力、先進的研究基礎設施以及對基因組學和轉錄組學研究日益成長的關注。基因表現分析在腫瘤學、遺傳疾病和精準醫療等領域的日益普及是市場成長的主要驅動力。次世代定序、PCR和微陣列等技術在研究和臨床應用中已廣泛應用，進一步推動了市場需求。此外，完善的法規結構、對基因組研究的大量投入以及分析技術的不斷進步也促進了市場擴張。
Thermo Fisher Scientific Inc.（美國）、Illumina, Inc.（美國）、Bio-Rad Laboratories, Inc.（美國）、QIAGEN（荷蘭）、F. Hoffmann-La Roche Ltd.（瑞士）、Revvity（美國）、PacBio（美國）、Agilent Technologies, Inc.（美國）、Sysx Corporation（日本）、BJen）、Agilent Technologies, Inc.（美國）、Sysx Corporation） BioTools（美國）、Oxford Nanopore Technologies plc（英國）、GenScript（美國）、Takara Bio Inc.（日本）、Danaher Corporation（美國）、Bruker（美國）、10X Genomics（美國）、Zymo Research Corporation（美國）、Twist Bioscience（美國）、Prome Technologies Corporation（美國）、CUSC（美國）、美國）（美國）（美國）（英國）,0me Technologies Corporation（美國）、美國）（美國）。 Biolabs（美國）是提供基因表現分析產品和服務的一些主要企業。
調查範圍
本研究報告根據產品供應（試劑和耗材[檢測試劑盒、酵素、DNA晶片和其他試劑和耗材]、儀器[PCR、NGS、DNA微陣列和其他儀器]、服務[基因表現分析服務{ 基因表現定序服務和其他服務}、生物資訊解決方案]）、應用（藥物發現和開發、臨床診斷和其他應用）、最終用戶（製藥和生物技術公司、學術和研究機構以及其他最終用戶）和地區（北美、歐洲、亞太地區、拉丁美洲以及中東和非洲）對基因表現分析市場進行了細分。
本報告詳細介紹了影響基因表現分析市場成長的關鍵因素，包括促進因素、限制因素、挑戰和機會。該報告對主要產業參與企業進行了全面分析，深入剖析了他們的業務概況、產品系列、關鍵策略、新產品發布、收購以及與基因表現表現分析市場相關的最新發展。此外，該報告也對基因表現分析產業生態系統中Start-Ups企業進行了競爭分析。
購買本報告的主要好處
本報告透過提供整體市場及其細分市場的收入預測，幫助市場領導和新參與企業。它還有助於相關人員更深入了解競爭格局，有效地進行業務定位，並制定合適的打入市場策略。透過本報告，相關人員可以掌握市場趨勢，並獲取有關關鍵市場促進因素、限制因素、機會和挑戰的資訊。
本報告深入分析了以下幾點：
- 影響市場成長的關鍵促進因素分析（基因表現分析在藥物發現和開發中的應用日益廣泛，在疾病研究中的應用不斷擴大，以及基於基因表現的診斷和預後測試的普及），阻礙因素（高成本，數據分析和解釋複雜），機會（單細胞分析技術的缺乏，以及基因表現分析在臨床和轉化研究中的標準化），以及標準化挑戰（缺乏）。
- 產品開發/創新：深入了解基因表現分析市場的新產品發布和創新。
- 市場開發：提供各地區盈利市場的全面資訊及市場分析。
- 市場多元化：基因表現分析市場的新產品、未開發地區、最新趨勢和投資的全面資訊。
- 競爭分析：主要企業－賽默飛世爾科技公司（美國）、Illumina公司（美國）、Bio-Rad Laboratories公司（美國）、QIAGEN（荷蘭）、羅氏公司（瑞士）、Revvity（美國）、PacBio（美國）、安捷倫科技公司（美國）、Sysmexx（日本） BioTools（美國）、Oxford Nanopore Technologies plc（英國）、金斯瑞生物技術有限公司（美國）、寶生物株式會社（日本）以及其他基因表現分析市場的主要企業。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 任務
- 未滿足的需求和未開發的領域
- 相互關聯的市場與跨產業機遇
- 一、二、三級公司的策略影片
第5章 產業趨勢
- 波特五力分析
- 宏觀經濟展望
- 價值鏈分析
- 生態系分析
- 價格分析
- 貿易分析
- 2026-2027 年主要會議和活動
- 影響客戶業務的趨勢/顛覆性因素
- 投資和資金籌措場景
- 案例研究分析
- 美國關稅對基因表現分析市場的影響
第6章：技術進步、人工智慧的影響、專利、創新與未來應用
- 主要技術
- 鄰近技術
- 技術藍圖
- 專利分析
- 未來應用
- AI/GEN：人工智慧對基因表現分析市場的影響
第7章：監理情勢與永續性舉措
- 當地法規和合規性
- 監管機構、政府機構和其他組織
- 業界標準
- 認證、標籤檢視和環境標準
- 對永續性的承諾
- 監理政策對永續性舉措的影響
第8章：顧客趨勢與購買行為
- 決策流程
- 採購過程中的關鍵相關人員及其評估標準
- 實施障礙和內部挑戰
- 各個終端用戶產業尚未滿足的需求
第9章：基因表現分析市場（依產品/服務分類）
- 試劑和耗材
- 裝置
- 軟體與服務
第10章：基因表現分析市場（依應用領域分類）
- 藥物發現與開發
- 臨床診斷
- 基礎研究與功能通路分析
- 其他
第11章：基因表現分析市場（依最終用戶分類）
- 製藥和生物技術公司
- 學術和研究機構
- 醫院和臨床檢查室
- 受託研究機構（CRO）
- 其他
第12章：基因表現分析市場（按地區分類）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東
- 海灣合作理事會國家
- 其他
- 非洲
第13章 競爭格局
- 主要參與企業的策略/優勢
- 2021-2025年收入分析
- 2025年市佔率分析
- 品牌對比
- 企業估值矩陣：主要企業，2025 年
- 公司估值矩陣：Start-Ups/中小企業，2025 年
- 企業估值和財務指標
- 競爭格局
第14章：公司簡介
- 主要參與企業
- THERMO FISHER SCIENTIFIC INC.
- BIO-RAD LABORATORIES, INC.
- ILLUMINA, INC.
- QIAGEN
- REVVITY
- F. HOFFMANN-LA ROCHE LTD.
- PACBIO
- AGILENT TECHNOLOGIES, INC.
- SYSMEX CORPORATION
- BGI
- EUROFINS SCIENTIFIC
- STANDARD BIOTOOLS
- OXFORD NANOPORE TECHNOLOGIES PLC
- GENSCRIPT
- TAKARA BIO INC.
- DANAHER CORPORATION
- BRUKER
- 其他公司
- 10X GENOMICS
- ZYMO RESEARCH CORPORATION
- TWIST BIOSCIENCE
- PROMEGA CORPORATION
- LGC LIMITED
- CD GENOMICS
- BIOSPYDER TECHNOLOGIES INC.
- NEW ENGLAND BIOLABS
第15章：調查方法
第16章附錄
Product Code: BT 2236
The gene expression analysis market is expected to reach USD 5.93 billion in 2031 from USD 4.23 billion in 2026, at a CAGR of 7.0% during the forecast period. The market is driven by the increasing adoption of transcriptomics technologies and the growing focus on precision medicine and personalized therapeutics. Techniques such as next-generation sequencing, PCR, and microarrays enable accurate and high-throughput analysis of gene activity, supporting advancements in disease research and diagnostics.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2026-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD billion) |
| Segments | Offering, Application, End User |
| Regions covered | North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa |
Furthermore, the rising use of gene expression profiling in biomarker discovery and drug development enhances research efficiency and clinical outcomes. However, high instrument costs, complex data analysis, and the need for skilled professionals continue to limit market growth.
"The reagents & consumables segment is expected to grow at the highest CAGR during the forecast period."
The reagents & consumables segment is projected to grow at the highest CAGR in the gene expression analysis market due to the repeated and high-volume usage of kits, enzymes, probes, and other consumables across research and clinical workflows. These products are essential for techniques such as PCR, next-generation sequencing, and microarray analysis, ensuring consistent demand. The increasing number of genomics and transcriptomics studies, along with the rising adoption of gene expression profiling in diagnostics and drug research, is further driving segment growth. Additionally, continuous product innovations and the need for reliable and high-quality reagents to ensure accurate results contribute to the expansion of this segment. Their cost-effectiveness and recurring purchase nature make reagents & consumables a key growth driver in the market.
"Drug discovery & development segment holds the largest share of the market."
The drug discovery & development segment accounts for the largest share of the gene expression analysis market, driven by the extensive use of gene expression profiling in identifying and validating drug targets. These technologies play a critical role in understanding gene function, disease pathways, and therapeutic responses, thereby improving the efficiency of drug development processes. Pharmaceutical and biotechnology companies increasingly rely on gene expression analysis for biomarker discovery, toxicity assessment, and efficacy evaluation. The growing focus on precision medicine and targeted therapies, along with rising R&D investments, further supports the dominance of this segment.
"The US is projected to grow at the highest CAGR during the forecast period."
The US is projected to grow at the highest CAGR in the gene expression analysis market due to its strong presence of leading biotechnology and pharmaceutical companies, advanced research infrastructure, and increasing focus on genomics and transcriptomics studies. Rising adoption of gene expression profiling in areas such as oncology, genetic disorders, and precision medicine is a key factor driving market growth. Technologies including next-generation sequencing, PCR, and microarrays are widely used across research and clinical applications, further boosting demand. Additionally, supportive regulatory frameworks, high funding for genomic research, and continuous advancements in analytical technologies contribute to market expansion.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side - 70% and Demand Side - 30%
- By Designation: Managers - 45%, CXOs and Directors - 30%, and Executives - 25%
- By Region: North America - 40%, Europe - 25%, Asia Pacific - 25%, Latin America - 5%, the Middle East & Africa - 5%
Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), PacBio (US), Agilent Technologies, Inc. (US), Sysmex Corporation (Japan), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc. (Japan), Danaher Corporation (US), Bruker (US), 10X Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), BioSpyder Technologies Inc. (US), and New England Biolabs (US) are some of the key companies offering gene expression analysis products & services.
Research Coverage
This research report categorizes the gene expression analysis market by offering (reagents & consumables[assays & kits, enzymes, DNA chips, other reagents & consumables], instruments [PCR, NGS, DNA microarray, other instruments], services [gene expression analysis services{RNA sequencing services, other services}, bioinformatics solutions]), application (drug discovery & development, clinical diagnostics, other applications), end user (pharmaceutical & biotechnology companies, academic & research institutes, other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East, And Africa).
The report's scope encompasses detailed information about the primary factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the gene expression analysis market. A comprehensive analysis of key industry players has been performed to provide insights into their business overview, product portfolio, key strategies, new product launches, acquisitions, and recent developments related to the gene expression analysis market. This report also includes a competitive analysis of emerging startups in the gene expression analysis industry ecosystem.
Key Benefits of Buying the Report
The report will assist market leaders and new entrants by providing revenue estimates for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their businesses effectively and develop suitable go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
- Analysis of key drivers (growing use of gene expression analysis in drug discovery and development, expanding applications in disease research, and rising adoption of gene expression-based diagnostics and prognostics tests), restraints (High cost of instruments and complexity of data analysis and interpretation), opportunities (growing adoption of single-cell analysis technologies and expansion of gene expression analysis in clinical and translational research), and challenges (lack of standardization) influencing the market growth
- Product Development/Innovation: Detailed insights into newly launched products and innovations in the gene expression analysis market
- Market Development: Comprehensive information about lucrative markets and analysis of the market across varied regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the gene expression analysis market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and products & services of leading players, Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), PacBio (US), Agilent Technologies, Inc. (US), Sysmex Corporation (Japan), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc. (Japan), among others, for the gene expression analysis market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN GENE EXPRESSION ANALYSIS MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW
- 3.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING
- 3.3 GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.4 GENE EXPRESSION ANALYSIS MARKET SHARE, BY OFFERING, 2026 VS 2031 (%)
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Growing use of gene expression analysis in drug discovery and development
- 4.2.1.2 Expanding applications in disease research
- 4.2.1.3 Rising adoption of gene expression-based diagnostics and prognostics tests
- 4.2.2 RESTRAINTS
- 4.2.2.1 High cost of instruments
- 4.2.2.2 Complexity of data analysis and interpretation
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Growing adoption of single-cell analysis technologies
- 4.2.3.2 Expansion of gene expression analysis in clinical and translational research
- 4.2.4 CHALLENGES
- 4.2.4.1 Lack of standardization
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 THREAT OF NEW ENTRANTS
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY
- 5.2.4 R&D TRENDS IN GLOBAL BIOTECH INDUSTRY
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 ECOSYSTEM ANALYSIS
- 5.4.1 ROLE OF PLAYERS IN ECOSYSTEM
- 5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025 (USD)
- 5.5.1.1 Instruments
- 5.5.1.2 Consumables
- 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025 (USD)
- 5.5.2.1 Instruments
- 5.5.2.2 Consumables
- 5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023-2025 (USD)
- 5.6 TRADE ANALYSIS
- 5.6.1 IMPORT SCENARIO (HS CODE 3822.00)
- 5.6.2 EXPORT SCENARIO (HS CODE 3822.00)
- 5.6.3 IMPORT SCENARIO (HS CODE 9027.00)
- 5.6.4 EXPORT SCENARIO (HS CODE 9027.00)
- 5.7 KEY CONFERENCES & EVENTS, 2026-2027
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.9 INVESTMENT & FUNDING SCENARIO
- 5.10 CASE STUDY ANALYSIS
- 5.10.1 RNA SEQUENCING ENABLES CLINICAL DIAGNOSTIC ADVANCEMENTS IN RARE GENETIC DISORDERS
- 5.10.2 TRANSCRIPTOMIC PROFILING IMPROVES BIOMARKER DETECTION IN ONCOLOGY
- 5.10.3 GENE EXPRESSION ANALYSIS ENABLES FUNCTIONAL INTERPRETATION IN RARE DISEASE DIAGNOSTICS
- 5.11 IMPACT OF US TARIFFS-GENE EXPRESSION ANALYSIS MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON COUNTRIES/REGIONS
- 5.11.4.1 US
- 5.11.4.2 Europe
- 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
- 5.11.5.1 Pharmaceutical & biotechnology companies
- 5.11.5.2 CROs and academic & research institutes
- 5.11.5.3 Clinical laboratories
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 INTRODUCTION
- 6.2 KEY TECHNOLOGIES
- 6.2.1 QUANTITATIVE PCR (QPCR)
- 6.2.2 MICROARRAY TECHNOLOGY
- 6.2.3 RNA SEQUENCING
- 6.3 ADJACENT TECHNOLOGIES
- 6.3.1 SINGLE-CELL ANALYSIS
- 6.3.2 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
- 6.3.3 SPATIAL BIOLOGY
- 6.4 TECHNOLOGY ROADMAP
- 6.5 PATENT ANALYSIS
- 6.5.1 METHODOLOGY
- 6.5.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
- 6.5.3 LIST OF KEY PATENTS
- 6.6 FUTURE APPLICATIONS
- 6.7 IMPACT OF AI/GEN AI ON GENE EXPRESSION ANALYSIS MARKET
- 6.7.1 TOP USE CASES AND MARKET POTENTIAL
- 6.7.2 BEST PRACTICES IN AI-ENABLED GENE EXPRESSION WORKFLOWS
- 6.7.3 CASE STUDIES RELATED TO AI IMPLEMENTATION IN GENE EXPRESSION ANALYSIS MARKET
- 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 6.7.5 CLIENTS' READINESS TO ADOPT AI-INTEGRATED GENERATIVE MOLECULAR DESIGN IN GENE EXPRESSION ANALYSIS MARKET
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 INDUSTRY STANDARDS
- 7.1.2.1 North America
- 7.1.2.2 Europe
- 7.1.2.3 Asia Pacific
- 7.1.2.4 Rest of the world
- 7.1.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
- 7.2 SUSTAINABILITY INITIATIVES
- 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9 GENE EXPRESSION ANALYSIS MARKET, BY OFFERING
- 9.1 INTRODUCTION
- 9.2 REAGENTS & CONSUMABLES
- 9.2.1 ASSAYS & KITS
- 9.2.1.1 Rising adoption of multi-omics and single-cell assay kits to drive market
- 9.2.1.2 RNA isolation kits
- 9.2.1.2.1 Increasing demand for high-quality RNA and integrated multi-omics workflows to drive market
- 9.2.1.3 cDNA synthesis kits
- 9.2.1.3.1 Growing demand for high-fidelity reverse transcription in advanced transcriptomics to drive market
- 9.2.1.4 Library preparation kits
- 9.2.1.4.1 Increasing adoption of high-throughput sequencing and multiomics workflows to drive market
- 9.2.1.5 PCR assays & kits
- 9.2.1.5.1 Expanding use of PCR-integrated workflows in diagnostics and precision medicine to drive market
- 9.2.1.6 Other assays & kits
- 9.2.2 ENZYMES
- 9.2.2.1 Advancements in high-fidelity, application-specific enzymes to drive market
- 9.2.3 DNA CHIPS
- 9.2.3.1 Increasing adoption of high-throughput DNA chips in large-scale genomics research to propel market
- 9.2.4 OTHER REAGENTS & CONSUMABLES
- 9.2.1 ASSAYS & KITS
- 9.3 INSTRUMENTS
- 9.3.1 PCR INSTRUMENTS
- 9.3.1.1 Increasing adoption of high-precision and automated PCR technologies to boost demand
- 9.3.2 NGS INSTRUMENTS
- 9.3.2.1 Expanding adoption of high-throughput NGS platforms to drive market
- 9.3.3 DNA MICROARRAY SCANNERS
- 9.3.3.1 Enhanced microarray performance and throughput to propel market
- 9.3.4 OTHER INSTRUMENTS
- 9.3.1 PCR INSTRUMENTS
- 9.4 SOFTWARE & SERVICES
- 9.4.1 GENE EXPRESSION ANALYSIS SERVICES
- 9.4.1.1 RNA sequencing services
- 9.4.1.1.1 Expanding transcriptomics research to propel market
- 9.4.1.2 Microarray analysis services
- 9.4.1.2.1 Increasing demand for standardized, high-throughput gene expression profiling in large-sample studies to propel market
- 9.4.1.3 qPCR profiling services
- 9.4.1.3.1 Increasing demand for precise gene expression quantification to propel market
- 9.4.1.4 Other gene expression analysis services
- 9.4.1.1 RNA sequencing services
- 9.4.2 BIOINFORMATICS SOLUTIONS
- 9.4.2.1 Rising demand for AI-driven bioinformatics solutions to support market growth
- 9.4.2.2 Bioinformatics & data analysis services
- 9.4.2.2.1 Rising complexity of multi-omics data and demand for AI-driven biological insights to drive market
- 9.4.2.3 Software
- 9.4.2.3.1 Gene expression databases
- 9.4.2.3.1.1 Increasing need for structured data management to drive market
- 9.4.2.3.2 Data analysis software & visualization tools
- 9.4.2.3.2.1 Increasing demand for simplified data analysis and effective visualization of complex gene expression datasets to drive market
- 9.4.2.3.3 Cloud-based analysis platforms
- 9.4.2.3.3.1 Increasing shift toward AI-enabled SaaS cloud ecosystems to drive market
- 9.4.2.3.1 Gene expression databases
- 9.4.1 GENE EXPRESSION ANALYSIS SERVICES
10 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 DRUG DISCOVERY & DEVELOPMENT
- 10.2.1 INCREASING AI-INTEGRATED TRANSCRIPTOMICS AND PRECISION MEDICINE TO PROPEL MARKET
- 10.3 CLINICAL DIAGNOSTICS
- 10.3.1 INTEGRATION OF AI-DRIVEN ANALYSIS AND ADVANCED MOLECULAR DIAGNOSTICS TO DRIVE MARKET
- 10.4 BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS
- 10.4.1 EXPANDING MULTI-OMICS RESEARCH AND AI-ENABLED BIOINFORMATICS PLATFORMS TO DRIVE MARKET
- 10.5 OTHER APPLICATIONS
11 GENE EXPRESSION ANALYSIS MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 11.2.1 STRATEGIC PHARMA-TECH COLLABORATIONS TO DRIVE MARKET
- 11.3 ACADEMIC & RESEARCH INSTITUTES
- 11.3.1 EXPANSION OF OPEN-ACCESS GENOMIC RESOURCES TO PROPEL MARKET
- 11.4 HOSPITALS & CLINICAL LABORATORIES
- 11.4.1 INTEGRATION OF PRECISION ONCOLOGY TO PROPEL MARKET
- 11.5 CONTRACT RESEARCH ORGANIZATIONS (CROS)
- 11.5.1 INCREASING OUTSOURCING OF COMPLEX GENOMIC RESEARCH AND CLINICAL TRIALS TO PROPEL MARKET
- 11.6 OTHER END USERS
12 GENE EXPRESSION ANALYSIS MARKET, BY REGION
- 12.1 INTRODUCTION
- 12.2 NORTH AMERICA
- 12.2.1 US
- 12.2.1.1 Rapid adoption of spatial transcriptomics and advanced genomics platforms to drive market
- 12.2.2 CANADA
- 12.2.2.1 Increasing incidence of chronic diseases to drive market
- 12.2.1 US
- 12.3 EUROPE
- 12.3.1 GERMANY
- 12.3.1.1 Expanding genomics infrastructure and advanced bioinformatics platforms to drive market
- 12.3.2 UK
- 12.3.2.1 National genomics initiatives and large-scale multiomics research to drive market
- 12.3.3 FRANCE
- 12.3.3.1 Increasing R&D in life sciences research to fuel market
- 12.3.4 ITALY
- 12.3.4.1 Expanding precision medicine research and adoption of advanced sequencing technologies to support market growth
- 12.3.5 SPAIN
- 12.3.5.1 Large-scale genomics programs to boost demand
- 12.3.6 REST OF EUROPE
- 12.3.1 GERMANY
- 12.4 ASIA PACIFIC
- 12.4.1 CHINA
- 12.4.1.1 Large-scale genomics program to boost demand
- 12.4.2 JAPAN
- 12.4.2.1 Integration of AI-driven genomics and precision oncology to propel market
- 12.4.3 INDIA
- 12.4.3.1 Expansion of national genomic databases to drive market
- 12.4.4 AUSTRALIA
- 12.4.4.1 National genomics integration to drive market
- 12.4.5 SOUTH KOREA
- 12.4.5.1 Government-led genomic data initiatives to boost demand
- 12.4.6 REST OF ASIA PACIFIC
- 12.4.1 CHINA
- 12.5 LATIN AMERICA
- 12.5.1 BRAZIL
- 12.5.1.1 Growth in the biopharmaceutical industry to support market
- 12.5.2 MEXICO
- 12.5.2.1 Increasing incidence of diabetes and growing geriatric population to propel market
- 12.5.3 REST OF LATIN AMERICA
- 12.5.1 BRAZIL
- 12.6 MIDDLE EAST
- 12.6.1 GCC COUNTRIES
- 12.6.1.1 Saudi Arabia
- 12.6.1.1.1 National genomics strategies and precision medicine integration to support market growth
- 12.6.1.2 United Arab Emirates
- 12.6.1.2.1 NGS-driven collaborations to fuel market
- 12.6.1.3 Rest of GCC Countries
- 12.6.1.1 Saudi Arabia
- 12.6.2 REST OF MIDDLE EAST
- 12.6.1 GCC COUNTRIES
- 12.7 AFRICA
- 12.7.1 EXPANDING GENOMICS RESEARCH CAPACITY AND DISEASE-FOCUSED INITIATIVES TO SUPPORT MARKET GROWTH
13 COMPETITIVE LANDSCAPE
- 13.1 INTRODUCTION
- 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2023-MARCH 2026
- 13.3 REVENUE ANALYSIS, 2021-2025
- 13.4 MARKET SHARE ANALYSIS, 2025
- 13.5 BRAND COMPARISON
- 13.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 13.6.1 STARS
- 13.6.2 EMERGING LEADERS
- 13.6.3 PERVASIVE PLAYERS
- 13.6.4 PARTICIPANTS
- 13.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 13.6.5.1 Company footprint
- 13.6.5.2 Region footprint
- 13.6.5.3 Offering footprint
- 13.6.5.4 Application footprint
- 13.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 13.7.1 PROGRESSIVE COMPANIES
- 13.7.2 RESPONSIVE COMPANIES
- 13.7.3 DYNAMIC COMPANIES
- 13.7.4 STARTING BLOCKS
- 13.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 13.7.5.1 Detailed list of key startups/SMEs
- 13.7.5.2 Competitive benchmarking of key startups/SMEs
- 13.8 COMPANY VALUATION & FINANCIAL METRICS
- 13.8.1 COMPANY VALUATION
- 13.8.2 FINANCIAL METRICS
- 13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
14 COMPANY PROFILES
- 14.1 KEY PLAYERS
- 14.1.1 THERMO FISHER SCIENTIFIC INC.
- 14.1.1.1 Business overview
- 14.1.1.2 Products/Services offered
- 14.1.1.3 Recent developments
- 14.1.1.3.1 Product launches
- 14.1.1.3.2 Deals
- 14.1.1.3.3 Expansions
- 14.1.1.4 MnM view
- 14.1.1.4.1 Key strengths
- 14.1.1.4.2 Strategic choices
- 14.1.1.4.3 Weaknesses and competitive threats
- 14.1.2 BIO-RAD LABORATORIES, INC.
- 14.1.2.1 Business overview
- 14.1.2.2 Products/Services offered
- 14.1.2.3 Recent developments
- 14.1.2.3.1 Product launches
- 14.1.2.3.2 Deals
- 14.1.2.4 MnM view
- 14.1.2.4.1 Key strengths
- 14.1.2.4.2 Strategic choices
- 14.1.2.4.3 Weaknesses and competitive threats
- 14.1.3 ILLUMINA, INC.
- 14.1.3.1 Business overview
- 14.1.3.2 Products/Services offered
- 14.1.3.3 Recent developments
- 14.1.3.3.1 Product launches
- 14.1.3.3.2 Deals
- 14.1.3.4 MnM view
- 14.1.3.4.1 Key strengths
- 14.1.3.4.2 Strategic choices
- 14.1.3.4.3 Weaknesses and competitive threats
- 14.1.4 QIAGEN
- 14.1.4.1 Business overview
- 14.1.4.2 Products/Services offered
- 14.1.4.3 Recent developments
- 14.1.4.3.1 Product launches
- 14.1.4.3.2 Deals
- 14.1.4.4 MnM view
- 14.1.4.4.1 Key strengths
- 14.1.4.4.2 Strategic choices
- 14.1.4.4.3 Weaknesses and competitive threats
- 14.1.5 REVVITY
- 14.1.5.1 Business overview
- 14.1.5.2 Products/Services offered
- 14.1.5.3 Recent developments
- 14.1.5.3.1 Deals
- 14.1.5.3.2 Expansions
- 14.1.5.4 MnM view
- 14.1.5.4.1 Key strengths
- 14.1.5.4.2 Strategic choices
- 14.1.5.4.3 Weaknesses and competitive threats
- 14.1.6 F. HOFFMANN-LA ROCHE LTD.
- 14.1.6.1 Business overview
- 14.1.6.2 Products/Services offered
- 14.1.6.3 Recent developments
- 14.1.6.3.1 Product launches
- 14.1.6.3.2 Deals
- 14.1.6.3.3 Other developments
- 14.1.7 PACBIO
- 14.1.7.1 Business overview
- 14.1.7.2 Products/Services offered
- 14.1.7.3 Recent developments
- 14.1.7.3.1 Product launches
- 14.1.7.3.2 Deals
- 14.1.7.3.3 Expansions
- 14.1.8 AGILENT TECHNOLOGIES, INC.
- 14.1.8.1 Business overview
- 14.1.8.2 Products/Services offered
- 14.1.9 SYSMEX CORPORATION
- 14.1.9.1 Business overview
- 14.1.9.2 Products/Services offered
- 14.1.9.3 Recent developments
- 14.1.9.3.1 Deals
- 14.1.9.3.2 Other developments
- 14.1.10 BGI
- 14.1.10.1 Business overview
- 14.1.10.2 Products/Services offered
- 14.1.11 EUROFINS SCIENTIFIC
- 14.1.11.1 Business overview
- 14.1.11.2 Products/Services offered
- 14.1.12 STANDARD BIOTOOLS
- 14.1.12.1 Business overview
- 14.1.12.2 Products/Services offered
- 14.1.12.3 Recent developments
- 14.1.12.3.1 Product launches
- 14.1.13 OXFORD NANOPORE TECHNOLOGIES PLC
- 14.1.13.1 Business overview
- 14.1.13.2 Products/Services offered
- 14.1.13.3 Recent developments
- 14.1.13.3.1 Deals
- 14.1.13.3.2 Expansions
- 14.1.14 GENSCRIPT
- 14.1.14.1 Business overview
- 14.1.14.2 Products/Services offered
- 14.1.14.3 Recent developments
- 14.1.14.3.1 Deals
- 14.1.14.3.2 Expansions
- 14.1.15 TAKARA BIO INC.
- 14.1.15.1 Business overview
- 14.1.15.2 Products/Services offered
- 14.1.15.3 Recent developments
- 14.1.15.3.1 Product launches
- 14.1.15.3.2 Deals
- 14.1.16 DANAHER CORPORATION
- 14.1.16.1 Business overview
- 14.1.16.2 Products/Services offered
- 14.1.16.3 Recent developments
- 14.1.16.3.1 Deals
- 14.1.17 BRUKER
- 14.1.17.1 Business overview
- 14.1.17.2 Products/Services offered
- 14.1.17.3 Recent developments
- 14.1.17.3.1 Deals
- 14.1.1 THERMO FISHER SCIENTIFIC INC.
- 14.2 OTHER PLAYERS
- 14.2.1 10X GENOMICS
- 14.2.2 ZYMO RESEARCH CORPORATION
- 14.2.3 TWIST BIOSCIENCE
- 14.2.4 PROMEGA CORPORATION
- 14.2.5 LGC LIMITED
- 14.2.6 CD GENOMICS
- 14.2.7 BIOSPYDER TECHNOLOGIES INC.
- 14.2.8 NEW ENGLAND BIOLABS
15 RESEARCH METHODOLOGY
- 15.1 RESEARCH DATA
- 15.1.1 SECONDARY DATA
- 15.1.1.1 Key data from secondary sources
- 15.1.2 PRIMARY DATA
- 15.1.2.1 Key data from primary sources
- 15.1.2.2 Key primary participants
- 15.1.2.3 Breakdown of primary interviews
- 15.1.2.4 Key industry insights
- 15.1.1 SECONDARY DATA
- 15.2 MARKET SIZE ESTIMATION
- 15.2.1 GLOBAL GENE EXPRESSION ANALYSIS MARKET ESTIMATION, 2025
- 15.2.2 SEGMENTAL MARKET SIZE ESTIMATION
- 15.3 MARKET GROWTH RATE PROJECTIONS
- 15.4 DATA TRIANGULATION
- 15.5 FACTOR ANALYSIS
- 15.6 RESEARCH ASSUMPTIONS
- 15.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT
16 APPENDIX
- 16.1 DISCUSSION GUIDE
- 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 16.3 CUSTOMIZATION OPTIONS
- 16.4 RELATED REPORTS
- 16.5 AUTHOR DETAILS
List of Tables
- TABLE 1 GENE EXPRESSION ANALYSIS MARKET: INCLUSIONS AND EXCLUSIONS
- TABLE 2 GENE EXPRESSION ANALYSIS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
- TABLE 3 GENE EXPRESSION ANALYSIS MARKET: PORTER'S FIVE FORCES
- TABLE 4 GENE EXPRESSION ANALYSIS MARKET: ROLE OF PLAYERS IN ECOSYSTEM
- TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2023-2025 (USD)
- TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2023-2025 (USD)
- TABLE 7 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2023-2025 (USD)
- TABLE 8 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY REGION, 2023-2025 (USD)
- TABLE 9 IMPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 10 EXPORT DATA FOR HS CODE 3822.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 11 IMPORT DATA FOR HS CODE 9027.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 12 EXPORT DATA FOR HS CODE 9027.00-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
- TABLE 13 GENE EXPRESSION ANALYSIS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026-MARCH 2027
- TABLE 14 RECIPROCAL TARIFF RATES ADJUSTED BY US
- TABLE 15 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
- TABLE 16 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015-2025
- TABLE 17 LIST OF KEY PATENTS IN GENE EXPRESSION ANALYSIS MARKET, 2023-2025
- TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN GENE EXPRESSION ANALYSIS MARKET
- TABLE 19 CLIENT'S READINESS TO ADOPT AI-INTEGRATED GENERATIVE MOLECULAR DESIGN IN GENE EXPRESSION ANALYSIS MARKET
- TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- TABLE 25 KEY BUYING CRITERIA, BY END USER
- TABLE 26 GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 27 GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 28 GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 29 NORTH AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 30 EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 31 ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 32 LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 33 MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 34 GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 35 GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 36 NORTH AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 37 EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 38 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 39 LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 40 MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 41 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 42 GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 43 RNA ISOLATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 44 NORTH AMERICA: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 45 EUROPE: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 ASIA PACIFIC: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 LATIN AMERICA: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 48 MIDDLE EAST: RNA ISOLATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 49 GCC COUNTRIES: RNA ISOLATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 50 CDNA SYNTHESIS KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 51 NORTH AMERICA: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 52 EUROPE: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 ASIA PACIFIC: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 LATIN AMERICA: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 55 MIDDLE EAST: CDNA SYNTHESIS KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 56 GCC COUNTRIES: CDNA SYNTHESIS KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 57 LIBRARY PREPARATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 58 NORTH AMERICA: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 59 EUROPE: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 ASIA PACIFIC: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 61 LATIN AMERICA: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 62 MIDDLE EAST: LIBRARY PREPARATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 63 GCC COUNTRIES: LIBRARY PREPARATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 64 PCR ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 65 NORTH AMERICA: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 66 EUROPE: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 67 ASIA PACIFIC: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 LATIN AMERICA: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 69 MIDDLE EAST: PCR ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 70 GCC COUNTRIES: PCR ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 71 OTHER ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 72 NORTH AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 73 EUROPE: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 74 ASIA PACIFIC: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 LATIN AMERICA: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 76 MIDDLE EAST: OTHER ASSAYS & KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 77 GCC COUNTRIES: OTHER ASSAYS & KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 78 GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 79 NORTH AMERICA: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 80 EUROPE: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 81 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 LATIN AMERICA: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 83 MIDDLE EAST: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 84 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ENZYMES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 85 GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 86 NORTH AMERICA: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 87 EUROPE: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 88 ASIA PACIFIC: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 89 LATIN AMERICA: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 90 MIDDLE EAST: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 91 GCC COUNTRIES: GENE EXPRESSION ANALYSIS DNA CHIPS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 92 OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 93 NORTH AMERICA: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 94 EUROPE: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 95 ASIA PACIFIC: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 96 LATIN AMERICA: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 97 MIDDLE EAST: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 98 GCC COUNTRIES: OTHER GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 99 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 100 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 101 EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 102 ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 103 LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 105 GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 106 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 107 PCR INSTRUMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 108 NORTH AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 EUROPE: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 110 ASIA PACIFIC: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 LATIN AMERICA: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 112 MIDDLE EAST: PCR INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 113 GCC COUNTRIES: PCR INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 114 NGS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 115 NORTH AMERICA: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 EUROPE: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 117 ASIA PACIFIC: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 118 LATIN AMERICA: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 MIDDLE EAST: NGS INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 120 GCC COUNTRIES: NGS INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 121 DNA MICROARRAY SCANNERS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 122 NORTH AMERICA: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 123 EUROPE: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 124 ASIA PACIFIC: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 LATIN AMERICA: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 MIDDLE EAST: DNA MICROARRAY SCANNERS MARKET, BY REGION 2024-2031 (USD MILLION)
- TABLE 127 GCC COUNTRIES: DNA MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 128 OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 129 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 130 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 131 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 133 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 134 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 135 GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 136 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 137 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 138 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 139 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 140 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 141 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 142 GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 143 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 144 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 145 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 146 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 147 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 149 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 150 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 151 RNA SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 152 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 154 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 155 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 156 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 157 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 158 MICROARRAY ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 159 NORTH AMERICA: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 160 EUROPE: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 161 ASIA PACIFIC: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 162 LATIN AMERICA: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 163 MIDDLE EAST: MICROARRAY ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 164 GCC COUNTRIES: MICROARRAY ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 165 QPCR PROFILING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 166 NORTH AMERICA: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 EUROPE: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 168 ASIA PACIFIC: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 169 LATIN AMERICA: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 MIDDLE EAST: QPCR PROFILING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 171 GCC COUNTRIES: QPCR PROFILING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 173 NORTH AMERICA: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 174 EUROPE: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 175 ASIA PACIFIC: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 176 LATIN AMERICA: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 MIDDLE EAST: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 178 GCC COUNTRIES: OTHER GENE EXPRESSION ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 179 GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 180 NORTH AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 181 EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 182 ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 183 LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 185 GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 186 GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 187 GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 188 NORTH AMERICA: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 189 EUROPE: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 190 ASIA PACIFIC: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 191 LATIN AMERICA: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 192 MIDDLE EAST: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 193 GCC COUNTRIES: GENE EXPRESSION BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 194 GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 195 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 196 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 197 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 199 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 200 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 201 GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 202 GENE EXPRESSION DATABASES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 203 NORTH AMERICA: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 204 EUROPE: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 205 ASIA PACIFIC: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 206 LATIN AMERICA: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 207 MIDDLE EAST: GENE EXPRESSION DATABASES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 208 GCC COUNTRIES: GENE EXPRESSION DATABASES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 209 GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 210 NORTH AMERICA: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 211 EUROPE: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 212 ASIA PACIFIC: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 213 LATIN AMERICA: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 214 MIDDLE EAST: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 215 GCC COUNTRIES: GENE EXPRESSION DATA ANALYSIS SOFTWARE & VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 216 CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 217 NORTH AMERICA: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 218 EUROPE: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 219 ASIA PACIFIC: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 220 LATIN AMERICA: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 221 MIDDLE EAST: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 222 GCC COUNTRIES: CLOUD-BASED GENE EXPRESSION ANALYSIS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 223 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 224 GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
- TABLE 225 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 226 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 227 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 228 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 229 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
- TABLE 230 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 231 GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 232 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 233 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 234 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 235 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 236 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 237 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 238 GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 239 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 240 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 241 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 242 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 243 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 244 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BASIC RESEARCH & FUNCTIONAL PATHWAY ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 245 GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 246 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 247 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 248 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 250 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 251 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 252 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 253 GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 254 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 255 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 256 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 257 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 258 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 259 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 260 GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 261 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 262 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 263 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 264 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 265 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 266 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 267 GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 268 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 269 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 270 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 271 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 272 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 273 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 274 GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 275 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 276 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 277 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 278 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 279 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 280 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 281 GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 282 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 283 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 284 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 285 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 286 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 287 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 288 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 289 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 290 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 291 NORTH AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 292 NORTH AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 293 NORTH AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 294 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 295 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 296 NORTH AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 297 NORTH AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 298 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 299 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 300 US: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 301 US: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 302 US: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 303 US: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 304 US: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 305 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 306 US: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 307 US: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 308 US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 309 US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 310 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 311 CANADA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 312 CANADA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 313 CANADA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 314 CANADA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 315 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 316 CANADA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 317 CANADA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 318 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 319 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 320 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 321 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 322 EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 323 EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 324 EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 325 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 326 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 327 EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 328 EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 329 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 330 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 331 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 332 GERMANY: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 333 GERMANY: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 334 GERMANY: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 335 GERMANY: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 336 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 337 GERMANY: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 338 GERMANY: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 339 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 340 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 341 UK: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 342 UK: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 343 UK: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 344 UK: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 345 UK: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 346 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 347 UK: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 348 UK: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 349 UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 350 UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 351 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 352 FRANCE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 353 FRANCE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 354 FRANCE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 355 FRANCE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 356 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 357 FRANCE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 358 FRANCE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 359 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 360 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 361 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 362 ITALY: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 363 ITALY: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 364 ITALY: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 365 ITALY: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 366 ITALY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 367 ITALY: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 368 ITALY: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 369 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 370 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 371 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 372 SPAIN: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 373 SPAIN: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 374 SPAIN: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 375 SPAIN: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 376 SPAIN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 377 SPAIN: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 378 SPAIN: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 379 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 380 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 381 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 382 REST OF EUROPE: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 383 REST OF EUROPE: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 384 REST OF EUROPE: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 385 REST OF EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 386 REST OF EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 387 REST OF EUROPE: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 388 REST OF EUROPE: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 389 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 390 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 391 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 392 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 393 ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 394 ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 395 ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 396 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 397 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 398 ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 399 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 400 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 401 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 402 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 403 CHINA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 404 CHINA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 405 CHINA GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 406 CHINA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 407 CHINA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 408 CHINA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 409 CHINA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 410 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 411 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 412 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 413 JAPAN: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 414 JAPAN: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 415 JAPAN: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 416 JAPAN: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 417 JAPAN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 418 JAPAN: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 419 JAPAN: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 420 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 421 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 422 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 423 INDIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 424 INDIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 425 INDIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 426 INDIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 427 INDIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 428 INDIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 429 INDIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 430 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 431 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 432 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 433 AUSTRALIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 434 AUSTRALIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 435 AUSTRALIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 436 AUSTRALIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 437 AUSTRALIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 438 AUSTRALIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 439 AUSTRALIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 440 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 441 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 442 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 443 SOUTH KOREA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 444 SOUTH KOREA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 445 SOUTH KOREA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 446 SOUTH KOREA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 447 SOUTH KOREA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 448 SOUTH KOREA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 449 SOUTH KOREA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 450 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 451 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 452 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 453 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 454 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 455 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 456 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 457 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 458 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 459 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 460 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 461 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 462 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 463 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 464 LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 465 LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 466 LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 467 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 468 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 469 LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 470 LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 471 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 472 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 473 BRAZIL: GENE EXPRESSION ANALYSIS MARKET BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 474 BRAZIL: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 475 BRAZIL: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 476 BRAZIL: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 477 BRAZIL: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 478 BRAZIL: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 BRAZIL: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 480 BRAZIL: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 481 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 482 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 483 MEXICO: GENE EXPRESSION ANALYSIS MARKET BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 484 MEXICO: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 485 MEXICO: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 486 MEXICO: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 487 MEXICO: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 488 MEXICO: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 489 MEXICO: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 490 MEXICO: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 491 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 492 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 493 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 494 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 495 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 496 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 497 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 498 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 499 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 500 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 501 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 502 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 503 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 504 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 505 MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 506 MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 507 MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 508 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 509 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 510 MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 511 MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 512 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 513 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 514 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 515 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 516 GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 517 GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 518 GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 519 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 520 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 521 GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 522 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 523 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 524 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 525 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 526 SAUDI ARABIA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 527 SAUDI ARABIA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 528 SAUDI ARABIA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 529 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 530 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 531 SAUDI ARABIA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 532 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 533 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 534 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 535 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 536 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 537 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 538 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 539 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 541 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 542 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 543 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 544 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 545 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 546 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 547 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 548 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 549 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 550 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 551 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 552 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 553 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 554 REST OF GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 555 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 556 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 557 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 558 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 559 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 560 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 561 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 562 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 563 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 564 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 565 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
- TABLE 566 AFRICA: GENE EXPRESSION ANALYSIS REAGENTS & CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 567 AFRICA: GENE EXPRESSION ANALYSIS ASSAYS & KITS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 568 AFRICA: GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 569 AFRICA: GENE EXPRESSION ANALYSIS SOFTWARE & SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 570 AFRICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 571 AFRICA: GENE EXPRESSION ANALYSIS BIOINFORMATICS SOLUTIONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 572 AFRICA: GENE EXPRESSION ANALYSIS SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 573 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 574 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 575 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2023-MARCH 2026
- TABLE 576 GENE EXPRESSION ANALYSIS MARKET: DEGREE OF COMPETITION
- TABLE 577 GENE EXPRESSION ANALYSIS MARKET: REGION FOOTPRINT
- TABLE 578 GENE EXPRESSION ANALYSIS MARKET: OFFERING FOOTPRINT
- TABLE 579 GENE EXPRESSION ANALYSIS MARKET: APPLICATION FOOTPRINT
- TABLE 580 GENE EXPRESSION ANALYSIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
- TABLE 581 GENE EXPRESSION ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- TABLE 582 GENE EXPRESSION ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 583 GENE EXPRESSION ANALYSIS MARKET: DEALS, JANUARY 2023- MARCH 2026
- TABLE 584 GENE EXPRESSION ANALYSIS MARKET: EXPANSIONS, JANUARY 2023- MARCH 2026
- TABLE 585 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 586 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
- TABLE 587 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 588 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023- MARCH 2026
- TABLE 589 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023- MARCH 2026
- TABLE 590 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 591 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 592 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 593 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2023- MARCH 2026
- TABLE 594 ILLUMINA, INC.: COMPANY OVERVIEW
- TABLE 595 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 596 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 597 ILLUMINA, INC.: DEALS, JANUARY 2023- MARCH 2026
- TABLE 598 QIAGEN: COMPANY OVERVIEW
- TABLE 599 QIAGEN: PRODUCTS/SERVICES OFFERED
- TABLE 600 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 601 QIAGEN: DEALS, JANUARY 2023- MARCH 2026
- TABLE 602 REVVITY: COMPANY OVERVIEW
- TABLE 603 REVVITY: PRODUCTS/SERVICES OFFERED
- TABLE 604 REVVITY: DEALS, JANUARY 2023- MARCH 2026
- TABLE 605 REVVITY: EXPANSIONS, JANUARY 2023- MARCH 2026
- TABLE 606 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
- TABLE 607 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
- TABLE 608 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 609 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023- MARCH 2026
- TABLE 610 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023- MARCH 2026
- TABLE 611 PACBIO: COMPANY OVERVIEW
- TABLE 612 PACBIO: PRODUCTS/SERVICES OFFERED
- TABLE 613 PACBIO: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 614 PACBIO: DEALS, JANUARY 2023- MARCH 2026
- TABLE 615 PACBIO: EXPANSIONS, JANUARY 2023- MARCH 2026
- TABLE 616 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 617 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 618 SYSMEX CORPORATION: COMPANY OVERVIEW
- TABLE 619 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
- TABLE 620 SYSMEX CORPORATION: DEALS, JANUARY 2023- MARCH 2026
- TABLE 621 SYSMEX CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023- MARCH 2026
- TABLE 622 BGI: COMPANY OVERVIEW
- TABLE 623 BGI: PRODUCTS/SERVICES OFFERED
- TABLE 624 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
- TABLE 625 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
- TABLE 626 STANDARD BIOTOOLS: COMPANY OVERVIEW
- TABLE 627 STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED
- TABLE 628 STANDARD BIOTOOLS: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 629 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
- TABLE 630 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED
- TABLE 631 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023- MARCH 2026
- TABLE 632 OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS, JANUARY 2023- MARCH 2026
- TABLE 633 GENSCRIPT: COMPANY OVERVIEW
- TABLE 634 GENSCRIPT: PRODUCTS/SERVICES OFFERED
- TABLE 635 GENSCRIPT: DEALS, JANUARY 2023- MARCH 2026
- TABLE 636 GENSCRIPT: EXPANSIONS, JANUARY 2023- MARCH 2026
- TABLE 637 TAKARA BIO INC.: COMPANY OVERVIEW
- TABLE 638 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
- TABLE 639 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2023- MARCH 2026
- TABLE 640 TAKARA BIO INC.: DEALS, JANUARY 2023- MARCH 2026
- TABLE 641 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 642 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
- TABLE 643 DANAHER CORPORATION: DEALS, JANUARY 2023- MARCH 2026
- TABLE 644 BRUKER: COMPANY OVERVIEW
- TABLE 645 BRUKER: PRODUCTS/SERVICES OFFERED
- TABLE 646 BRUKER: DEALS, JANUARY 2023- MARCH 2026
- TABLE 647 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
- TABLE 648 RISK ASSESSMENT
List of Figures
- FIGURE 1 GENE EXPRESSION ANALYSIS MARKET SEGMENTATION AND REGIONS CONSIDERED
- FIGURE 2 GENE EXPRESSION ANALYSIS MARKET: YEARS CONSIDERED
- FIGURE 3 MARKET SCENARIO
- FIGURE 4 GLOBAL GENE EXPRESSION ANALYSIS MARKET, 2024-2031
- FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN GENE EXPRESSION ANALYSIS MARKET, 2023-2026
- FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF GENE EXPRESSION ANALYSIS MARKET
- FIGURE 7 HIGH-GROWTH SEGMENTS IN GENE EXPRESSION ANALYSIS MARKET, 2026-2031
- FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN GENE EXPRESSION ANALYSIS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 9 GROWING USE OF GENE EXPRESSION ANALYSIS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET GROWTH
- FIGURE 10 REAGENTS & CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF GENE EXPRESSION ANALYSIS MARKET IN NORTH AMERICA IN 2025
- FIGURE 11 ASIA PACIFIC COUNTRIES TO REGISTER HIGH GROWTH RATES DURING FORECAST PERIOD
- FIGURE 12 REAGENTS & CONSUMABLES TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 13 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 14 GENE EXPRESSION ANALYSIS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 15 GENE EXPRESSION ANALYSIS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 16 GENE EXPRESSION ANALYSIS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 17 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2025 (USD)
- FIGURE 18 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD)
- FIGURE 19 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2025 (USD)
- FIGURE 20 AVERAGE SELLING PRICE OF CONSUMABLES, BY REGION, 2025 (USD)
- FIGURE 21 GENE EXPRESSION ANALYSIS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 22 INVESTMENT AND FUNDING SCENARIO, 2023-2025 (USD MILLION)
- FIGURE 23 PATENT APPLICATIONS IN GENE EXPRESSION ANALYSIS MARKET, JANUARY 2015-DECEMBER 2025
- FIGURE 24 IMPACT OF AI/GEN AI ON GENE EXPRESSION ANALYSIS MARKET
- FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
- FIGURE 26 KEY BUYING CRITERIA, BY END USER
- FIGURE 27 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT
- FIGURE 28 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT
- FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE GENE EXPRESSION ANALYSIS MARKET, 2021-2025 (USD MILLION)
- FIGURE 30 MARKET SHARE ANALYSIS, 2025
- FIGURE 31 GENE EXPRESSION ANALYSIS MARKET: BRAND COMPARATIVE ANALYSIS
- FIGURE 32 GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 33 GENE EXPRESSION ANALYSIS MARKET: COMPANY FOOTPRINT
- FIGURE 34 GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 36 EV/EBITDA OF KEY VENDORS
- FIGURE 37 THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT (2025)
- FIGURE 38 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 39 ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 40 QIAGEN: COMPANY SNAPSHOT (2025)
- FIGURE 41 REVVITY: COMPANY SNAPSHOT (2025)
- FIGURE 42 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
- FIGURE 43 PACBIO: COMPANY SNAPSHOT (2025)
- FIGURE 44 AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT (2025)
- FIGURE 45 SYSMEX CORPORATION: COMPANY SNAPSHOT (2024)
- FIGURE 46 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
- FIGURE 47 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2025)
- FIGURE 48 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2025)
- FIGURE 49 GENSCRIPT: COMPANY SNAPSHOT (2024)
- FIGURE 50 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
- FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 52 BRUKER: COMPANY SNAPSHOT (2025)
- FIGURE 53 GENE EXPRESSION ANALYSIS MARKET: RESEARCH DESIGN
- FIGURE 54 GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 55 GENE EXPRESSION ANALYSIS MARKET: INSIGHTS FROM PRIMARIES
- FIGURE 56 GLOBAL GENE EXPRESSION ANALYSIS MARKET ESTIMATION, 2025
- FIGURE 57 GENE EXPRESSION ANALYSIS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
- FIGURE 58 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE ANALYSIS (2025)
- FIGURE 59 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
- FIGURE 60 GENE EXPRESSION ANALYSIS MARKET: CAGR PROJECTIONS
- FIGURE 61 GENE EXPRESSION ANALYSIS MARKET: DATA TRIANGULATION
02-2729-4219
+886-2-2729-4219
螢光素酶檢測市場：2026年至2032年全球市場預測（按產品類型、檢測類型、檢測儀器、技術、研究領域、應用和最終用戶分類）基因分析市場：按產品類型、技術、應用和最終用戶分類－2026-2032年全球市場預測基因表現分析市場：依產品類型、技術、疾病類型、應用和最終用戶分類－2026-2032年全球市場預測
全球基因表現分析市場規模、佔有率、趨勢和成長分析報告（2026-2034）
光遺傳學執行器和致動器市場分析及預測（至2035年）：按類型、產品類型、服務、技術、組件、應用、設備、最終用戶和功能分類2026-2034年全球光遺傳學執行器和感測器市場規模、佔有率、趨勢和成長分析報告
光遺傳學致動器和感測器市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、疾病類型、地區和競爭格局分類，2021-2031年基因表現篩檢服務市場按技術、產品類型、標靶和最終用戶分類，全球預測（2026-2032）
基因表現分析市場規模、佔有率和成長分析（按產品、製程、產能、技術、應用和地區分類）－產業預測，2026-2033年基因表現市場－全球產業規模、佔有率、趨勢、機會及預測，依製程、產品、產能、應用、技術、地區及競爭格局分類，2020-2030年預測
▼